Avanos Medical Inc. (AVNS)
NYSE · Healthcare
Avanos Medical Inc. Shareholder Equity 2012–2025
Avanos Medical Inc. annual shareholder equity history from 2013 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Avanos Medical Inc. shareholder equity as of December 31, 2025: 778.2M, a 6.07% decrease year-over-year.
- Avanos Medical Inc. shareholder equity for 2025 were 778.2M, a 6.07% decrease from 2024.
- Avanos Medical Inc. shareholder equity for 2024 were 828.5M, a 32.99% decrease from 2023.
- Avanos Medical Inc. shareholder equity for 2023 were 1.24B, a 4.25% decrease from 2022.
- Avanos Medical Inc. shareholder equity for 2022 were 1.29B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Avanos Medical Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $778 |
| 2024 | $829 |
| 2023 | $1,236 |
| 2022 | $1,291 |
| 2021 | $1,271 |
| 2020 | $1,262 |
| 2019 | $1,273 |
| 2018 | $1,297 |
| 2017 | $1,215 |
| 2016 | $1,103 |
| 2015 | $1,055 |
| 2014 | $1,491 |
| 2013 | $2,079 |
Avanos Medical Inc. Shareholder Equity — FAQ
Avanos Medical Inc. (AVNS) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVNS's shareholder equity history?
The chart and table above show Avanos Medical Inc.'s shareholder equity by year and by quarter, including the growth rate.